TUDOR INVESTMENT CORP ET AL - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 310 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$5,793,000
+193.6%
50,400
+299.1%
0.20%
+183.1%
Q3 2014$1,973,000
+788.7%
12,629
+601.6%
0.07%
+688.9%
Q2 2014$222,000
-71.1%
1,800
-75.7%
0.01%
-71.9%
Q1 2014$767,000
+166.3%
7,400
+131.2%
0.03%
+128.6%
Q4 2013$288,000
-48.8%
3,200
-61.9%
0.01%
-39.1%
Q3 2013$562,000
+97.9%
8,400
+95.3%
0.02%
+9.5%
Q2 2013$284,0004,3000.02%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders